Search all trials

Find therapies in clinical trials near you

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Bladder transitional cell carcinoma+1

Recruiting

Registered drug

A study of loxo-435, enfortumab vedotin, and pembrolizumab in adults with advanced or metastatic bladder cancer

Registered drug

Poland

Participants:18–64 years · 65+ years
Substances:Enfortumab Vedotin

Contact Research Centre

Urinary incontinence+1

Recruiting

Investigational

Orforglipron for stress urinary incontinence in women with obesity or overweight

Investigational

Poland

Participants:18–64 years

Contact Research Centre

Study on Baxdrostat and Dapagliflozin for Preventing Heart Failure in Patients at High Risk

Recruiting

Registered drug

Study on Baxdrostat and Dapagliflozin for Preventing Heart Failure in Patients at High Risk

Registered drug

Poland

Participants:18–64 years · 65+ years
Substances:Baxdrostat

Contact Research Centre

Chronic obstructive pulmonary disease

Recruiting

Registered drugNo placebo

Study on the Effects of Budesonide, Glycopyrronium, and Formoterol Fumarate for Patients with Chronic Obstructive Pulmonary Disease (COPD)

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Budesonide

Contact Research Centre

Transitional cell carcinoma

Recruiting

Registered drugNo placebo

Adjuvant Datopotamab Deruxtecan with Drug Combination in Patients with High‑Risk Muscle‑Invasive Urothelial Carcinoma

Registered drugNo placebo

Poland

Participants:18–64 years
Substances:Durvalumab

Contact Research Centre

Polycythaemia vera

Recruiting

Investigational

A Phase 3 Study of Sapablursen Compared with Placebo in Adults with Polycythemia Vera

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:Sapablursen

Contact Research Centre

Heart failure with preserved ejection fraction

Recruiting

Registered drug

Effect of elecoglipron plus dapagliflozin on cardiovascular outcomes in adults with heart failure with preserved or mildly reduced ejection fraction (HFpEF/HFmrEF)

Registered drug

Poland

Participants:18–64 years · 65+ years
Substances:Azd5004

Contact Research Centre

Mantle cell lymphoma

Recruiting

Registered drug

Phase 3 Study of Orelabrutinib with Rituximab and Bendamustine vs. Rituximab and Bendamustine in Treatment‑Naïve Mantle Cell Lymphoma Patients

Registered drug

Poland

Participants:18–64 years · 65+ years
Substances:Rituximab

Contact Research Centre

Myelofibrosis+1

Recruiting

Registered drug

Study of pelabresib (DAK539) plus ruxolitinib versus placebo plus ruxolitinib in adult patients with myelofibrosis who are JAK‑inhibitor‑naive

Registered drug

Poland

Participants:18–64 years · 65+ years
Substances:Ruxolitinib

Contact Research Centre

Myasthenia gravis

Recruiting

Registered drug

AUR200 for Patients with Generalized Myasthenia Gravis

Registered drug

Poland

Participants:18–64 years · 65+ years
Substances:AUR200

Contact Research Centre

Renal cell carcinoma

Recruiting

Registered drug

Belzutifan and Zanzalintinib in Adults with Advanced Renal Cell Carcinoma After PD-1/L1 and VEGF-TKI Therapy

Registered drug

Poland

Participants:18–64 years · 65+ years
Substances:Belzutifan

Contact Research Centre

Anaemia+1

Recruiting

Registered drugNo placebo

A Phase 3 Study of Elritercept Versus Epoetin Alfa in ESA‑Naïve Adults with Lower‑Risk Myelodysplastic Syndrome Requiring Red Blood Cell Transfusions

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Elritercept

Contact Research Centre

Find therapies in clinical trials near you

97 trials match your criteria

Bladder transitional cell carcinoma+1

A study of loxo-435, enfortumab vedotin, and pembrolizumab in adults with advanced or metastatic bladder cancer

Urinary incontinence+1

Orforglipron for stress urinary incontinence in women with obesity or overweight

Study on Baxdrostat and Dapagliflozin for Preventing Heart Failure in Patients at High Risk

Study on Baxdrostat and Dapagliflozin for Preventing Heart Failure in Patients at High Risk

Chronic obstructive pulmonary disease

Study on the Effects of Budesonide, Glycopyrronium, and Formoterol Fumarate for Patients with Chronic Obstructive Pulmonary Disease (COPD)

Transitional cell carcinoma

Adjuvant Datopotamab Deruxtecan with Drug Combination in Patients with High‑Risk Muscle‑Invasive Urothelial Carcinoma

Polycythaemia vera

A Phase 3 Study of Sapablursen Compared with Placebo in Adults with Polycythemia Vera

Heart failure with preserved ejection fraction

Effect of elecoglipron plus dapagliflozin on cardiovascular outcomes in adults with heart failure with preserved or mildly reduced ejection fraction (HFpEF/HFmrEF)

Mantle cell lymphoma

Phase 3 Study of Orelabrutinib with Rituximab and Bendamustine vs. Rituximab and Bendamustine in Treatment‑Naïve Mantle Cell Lymphoma Patients

Myelofibrosis+1

Study of pelabresib (DAK539) plus ruxolitinib versus placebo plus ruxolitinib in adult patients with myelofibrosis who are JAK‑inhibitor‑naive

Myasthenia gravis

AUR200 for Patients with Generalized Myasthenia Gravis

Renal cell carcinoma

Belzutifan and Zanzalintinib in Adults with Advanced Renal Cell Carcinoma After PD-1/L1 and VEGF-TKI Therapy

Anaemia+1

A Phase 3 Study of Elritercept Versus Epoetin Alfa in ESA‑Naïve Adults with Lower‑Risk Myelodysplastic Syndrome Requiring Red Blood Cell Transfusions

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.